Ebola: Durable immunity generated in non-human primates
Nature Medicine
2014년9월8일
Long-term immunity to the highly lethal Zaire ebolavirus (EBOV), which is currently spreading through West Africa, has been induced in macaques using a vaccine based on the chimpanzee-derived adenovirus vector, ChAd3, for which Phase 1 human trials have just been announced. The research, published in Nature Medicine this week, found that a prime-boost vaccine regimen, in which animals are first inoculated with ChAd3 coding for an ebolavirus glycoprotein (GP), and eight weeks later inoculated with a different vector MVA (modified vaccine Ankara) carrying the same gene, is the most effective, although a single shot with the ChAd3 vaccine also provided complete short-term and partial long-term protection. This was the first vaccination regime to be found to provide protection to the virus a full ten months after administration; previous tests challenged animals at only four to five weeks after vaccination.
Nancy Sullivan and colleagues selected chimpanzee adenoviruses rather than human adenoviruses-which have been used in some previous efforts to develop an effective ebolavirus vaccine-because many humans have already been exposed to human adenoviruses and therefore their immune systems are primed to neutralize them. They undertook preclinical trials of these vaccines in a small number of macaques. Long-term protection correlated with the abundance of effector and memory T immune cells, associated with host defense.
Although the macaques were challenged only with EBOV, because the vaccines contained genes coding for the glycoproteins from both EBOV and another commonly occurring ebolavirus species, Sudan ebolavirus (SUDV), it is possible that the vaccine will protect against both strains.
The authors conclude that the rapid-onset vaccine protection with durable immunity could potentially help contain the spread of emerging ebolaviruses.
doi: 10.1038/nm.3702
리서치 하이라이트
-
6월29일
COVID-19: Assessing instances of long COVID in UK health dataNature Communications
-
6월24일
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
6월23일
Scientific community: Women credited less than men in scientific paper authorshipNature
-
6월17일
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
6월16일
An exercise-inducible molecule that suppresses appetiteNature
-
6월16일
Cancer: Signatures of structural genomic variation in cancerNature